BioSpace News Archive

The aim is to prove the overall healthcare benefits of testing hereditary pancreatic cancer patients.

The joimax announces very strong sales figures for 2017.

Cosentyx is currently the only fully human IL-17A antagonist to demonstrate efficacy and safety in a dedicated Phase IIIb study of scalp psoriasis.

Net sales amounted to SEK 170.1 million, an increase of 23%.

Enamine and BioSolveIT announced the launch of the ‘REAL Space Navigator’. Jointly developed, the new software tool capitalizes on Enamine’s REAL (readily accessible) virtual compound concept and provides efficient ‘search & find’ access to more than 640 million pharma-oriented molecules, to date the world’s largest chemical space of commercially accessible compounds.

An investor conference call will be held at 8:00 a.m. (ET) on Thursday, February 22, 2018.

Medidata announced today that its virtual trials platform, Engage, is now being offered as a part of the Medidata Clinical Cloud, providing researchers unmatched flexibility to conduct clinical trials virtually, on-site, or as a hybrid.

Evelo Biosciences today announced the expansion of its executive leadership team with the appointment of Duncan McHale, M.D., Ph.D. as CMO and Michael Garcia-Webb, Ph.D. as head of people and operational excellence.

Bonti announced the initiation of the SHINE (Scar Healing Improvement with Neurotoxin E) clinical program, aimed at scar reduction using its novel neurotoxin.

Q Biomed is pleased to announce an exclusive option agreement with Washington University in St. Louis.